Rowinsky Eric K

The estimated Net Worth of Rowinsky Eric K is at least $7 Million dollars dollars as of 10/26/2021. Rowinsky Eric K is the Director of Navidea Biopharmaceuticals Inc. Rowinsky Eric K owns over 750 shares of Navidea Biopharmaceuticals Inc stock worth over $1,245.00. Rowinsky Eric K is the Director of Biogen Inc. Rowinsky Eric K owns over 11,310 shares of Biogen Inc stock worth over $3 Million dollars . Rowinsky Eric K is the Director of Fortress Biotech Inc. Rowinsky Eric K owns over 720,000 shares of Fortress Biotech Inc stock worth over $2 Million dollars . Rowinsky Eric K is the Chief Medical Officer of Stemline Therapeutics Inc. Rowinsky Eric K owns over 143,688 shares of Stemline Therapeutics Inc stock worth over $2 Million dollars .

Rowinsky Eric K mailing address: IMCLONE SYSTEMS INCORPORATED 180 VARICK STREET, 6TH FLOOR NEW YORK NY 10014

Insider Roles

Name Transaction Date Position
Verastem Inc 2020-06-16 director
Biogen Inc 2020-06-03 director
Fortress Biotech Inc 2020-01-01 director
Navidea Biopharmaceuticals Inc 2018-02-20 director
DNIB Unwind Inc 2016-08-29 director
Stemline Therapeutics Inc 2015-04-27 officer: Chief Medical Officer
Savara Inc 2010-06-30 director
EMBED
SAVE

Rowinsky Eric K trading performance

Average Relative Return

61.2%

Average relative return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .

Rowinsky Eric K trading performance analysis

1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 22 -16.4 31.2 61.2 13.6 -49.2
Relative Return to S&P 500(%) 15.19 -22.63 10.04 34.97 -32.68 -125.33

Rowinsky Eric K trading transactions

Ticker Company Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost(000) Final Share Price Change Since Insider Trade (%) Dividend Yield % PE Ratio Market Cap ($M)
FBIO
Fortress Biotech Inc
$3.15
Rowinsky Eric K
Director
2021-03-02 Sell
30,000
-4%
$4.24
$127.20
720,000
-25.71%
0
At Loss
318.35
STML
Stemline Therapeutics Inc
$11.83
Rowinsky Eric K
Chief Medical Officer
2015-04-27 Sell
10,824
-7.01%
$15.77
$170.69
143,688
-24.98%
0
At Loss
621.20
BIIB
Biogen Inc
$269.94
Rowinsky Eric K
Director
2015-03-20 Sell
11,667
-50.78%
$475
$5,541.82
11,310
-43.17%
0
26.40
39,652.22
BIIB
Biogen Inc
$269.94
Rowinsky Eric K
Director
2015-03-19 Sell
2,333
-17.10%
$436.14
$1,017.51
11,310
-38.11%
0
26.40
39,652.22
BIIB
Biogen Inc
$269.94
Rowinsky Eric K
Director
2015-03-17 Sell
4,667
-29.21%
$425.45
$1,985.58
11,310
-36.55%
0
26.40
39,652.22
BIIB
Biogen Inc
$269.94
Rowinsky Eric K
Director
2015-03-09 Sell
4,666
-29.21%
$417.23
$1,946.80
11,310
-35.30%
0
26.40
39,652.22
STML
Stemline Therapeutics Inc
$11.83
Rowinsky Eric K
Chief Medical Officer
2015-02-18 Sell
1,640
-1.24%
$13.99
$22.94
130,133
-15.44%
0
At Loss
621.20
STML
Stemline Therapeutics Inc
$11.83
Rowinsky Eric K
Chief Medical Officer
2014-04-25 Sell
11,179
-7.82%
$15.03
$168.02
131,773
-21.29%
0
At Loss
621.20
BIIB
Biogen Inc
$269.94
Rowinsky Eric K
Director
2014-01-21 Sell
2,020
-16.21%
$310.09
$626.38
10,440
-12.95%
0
26.40
39,652.22
BIIB
Biogen Inc
$269.94
Rowinsky Eric K
Director
2012-01-06 Sell
12,992
-58.72%
$116
$1,507.07
9,135
132.71%
0
26.40
39,652.22
NAVB
Navidea Biopharmaceuticals Inc
$1.66
Rowinsky Eric K
Director
2011-08-19 Buy
15,000
100%
$2.55
$38.25
750
-34.90%
0
At Loss
50.07
Total 11
  • 1

Rowinsky Eric K personal network

Name Position Linked company